X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1524) 1524
life sciences & biomedicine (1486) 1486
humans (1232) 1232
alk (1012) 1012
oncology (909) 909
female (581) 581
male (561) 561
anaplastic lymphoma kinase (493) 493
lung cancer (481) 481
receptor protein-tyrosine kinases - genetics (473) 473
lymphomas (469) 469
middle aged (448) 448
mutation (444) 444
lung neoplasms - genetics (424) 424
adult (422) 422
hemic and lymphatic diseases (411) 411
crizotinib (372) 372
aged (336) 336
immunohistochemistry (336) 336
lung neoplasms - drug therapy (334) 334
pathology (316) 316
carcinoma, non-small-cell lung - genetics (312) 312
carcinoma, non-small-cell lung - drug therapy (304) 304
lung neoplasms - pathology (303) 303
lung cancer, non-small cell (285) 285
receptor protein-tyrosine kinases - metabolism (264) 264
cancer (255) 255
kinases (251) 251
non-small cell lung cancer (251) 251
gene rearrangement (250) 250
tumors (235) 235
protein kinase inhibitors - therapeutic use (229) 229
animals (226) 226
egfr (216) 216
respiratory system (213) 213
genetic aspects (209) 209
nsclc (209) 209
carcinoma, non-small-cell lung - pathology (204) 204
receptor protein-tyrosine kinases - antagonists & inhibitors (192) 192
chemotherapy (191) 191
protein-tyrosine kinase (191) 191
aged, 80 and over (187) 187
in situ hybridization, fluorescence (186) 186
lymphoma (182) 182
antineoplastic agents - therapeutic use (180) 180
prognosis (178) 178
anaplastic large cell lymphoma (173) 173
receptor protein-tyrosine kinases (173) 173
metastasis (170) 170
analysis (167) 167
protein-tyrosine kinases - genetics (165) 165
patients (162) 162
adenocarcinoma (160) 160
care and treatment (153) 153
adenocarcinoma - genetics (150) 150
cell line, tumor (150) 150
research (150) 150
tyrosine (150) 150
oncogene proteins, fusion - genetics (149) 149
cell biology (148) 148
protein kinase inhibitors - pharmacology (147) 147
neuroblastoma (139) 139
neoplasms. tumors. oncology. including cancer and carcinogens (138) 138
non-small cell lung carcinoma (138) 138
cancer therapies (137) 137
protein-tyrosine kinases - metabolism (137) 137
pharmacology & pharmacy (135) 135
alectinib (132) 132
proteins (132) 132
alk protein (130) 130
hematology, oncology and palliative medicine (130) 130
review (129) 129
pyridines - therapeutic use (127) 127
pyrazoles - therapeutic use (126) 126
hematology (123) 123
child (119) 119
treatment outcome (119) 119
adolescent (115) 115
lung neoplasms - diagnosis (115) 115
lung neoplasms - metabolism (114) 114
anaplastic lymphoma kinase - genetics (113) 113
lymphoma, large-cell, anaplastic - pathology (113) 113
ceritinib (112) 112
health aspects (111) 111
fluorescence in situ hybridization (110) 110
genes (109) 109
biochemistry & molecular biology (108) 108
mice (108) 108
neoplasm staging (107) 107
case report (105) 105
lung neoplasms - enzymology (103) 103
diagnosis (101) 101
retrospective studies (100) 100
young adult (100) 100
translocation, genetic (99) 99
antineoplastic agents - pharmacology (98) 98
non-small-cell lung cancer (98) 98
pulmonary/respiratory (96) 96
respiratory tract diseases (96) 96
biomarkers, tumor - genetics (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2051) 2051
Chinese (56) 56
Japanese (16) 16
French (8) 8
German (6) 6
Korean (4) 4
Russian (3) 3
Spanish (2) 2
Italian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biochemical journal, ISSN 1470-8728, 05/2009, Volume 420, Issue 3, pp. 345 - 361
... (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t... 
Extracellular-signal-regulated kinase (ERK) | Pleiotrophin | Anaplastic large cell lymphoma (ALCL) | Neuroblastoma | Non-small cell lung cancer (NSLCL) | Midkine | Anaplastic lymphoma kinase (ALK) | Inflammatory myofibroblastic tumour (IMT) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Neuroblastoma - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases | Protein-Tyrosine Kinases - genetics | Models, Biological | Oncogene Proteins, Fusion - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Neuroblastoma - metabolism | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Neuroblastoma - pathology | Lymphoma, Large-Cell, Anaplastic - genetics | Index Medicus | ALK, anaplastic lymphoma kinase | LTK, leucocyte tyrosine kinase | MUC-1, mucin-1 | IRS-1, IR substrate-1 | PTN, pleiotrophin | TGFβ, transforming growth factor β | neuroblastoma | extracellular-signal-regulated kinase (ERK) | pleiotrophin | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | Shc, Src homology and collagen homology | TPM, tropomyosin | IMP cyclohydrolase | MK, midkine | MYH9, non-muscle myosin heavy chain | MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu | NPM, nucleophosmin | mTOR, mammalian target of rapamycin | NIPA, nuclear interacting partner of ALK | RPTP, receptor protein tyrosine phosphatase | inflammatory myofibroblastic tumour (IMT) | DLBCL, diffuse large B-cell lymphoma | FOXO3a, forkhead box O 3a | NF-κB, nuclear factor κB | Shp1, SH2 domain-containing phosphatase 1 | RANBP2, Ran-binding protein 2 | ALCL, anaplastic large cell lymphoma | Dpp, decapentaplegic | FRS2, fibroblast growth factor receptor substrate 2 | LDLa, low-density lipoprotein class A | EGFR, epidermal growth factor receptor | SEC31L1, SEC31 homologue A | GIST, gastrointestinal stromal tumour | RTK, receptor tyrosine kinase | SH2, Src homology 2 | TFG, TRK-fused gene | ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase | midkine | CLTC, clathrin heavy chain | anaplastic large cell lymphoma (ALCL) | MAPK, mitogen-activated protein kinase | Hen-1, hesitation-1 | MEK, MAPK | PI3K, phosphoinositide 3-kinase | HEK, human embryonic kidney | SCD-2, suppressor of constitutive dauer 2 | Review | EBPβ, CCAAT | CARS, cysteinyl-tRNA synthetase | JNK, c-Jun N-terminal kinase | ERK kinase | Grb2, growthfactor-receptor-bound protein 2 | SCC, squamous cell carcinoma | EML4, echinoderm microtubule-associated protein like 4 | SHH, sonic hedghog | BCR-Abl, breakpoint cluster region-Abl | IR, insulin receptor | ALO17, ALK lymphoma oligomerization partner on chromosome 17 | enhancer-binding protein β | PLCγ, phospholipase Cγ | NSCLC, non-small cell lung cancer | UCN-01, unco-ordinated 1 | non-small cell lung cancer (NSLCL) | Cdc42, cell division cycle 42 | STAT, signal transducer and activator of transcription | anaplastic lymphoma kinase (ALK) | DRG, dorsal root ganglia | MSN, moesin | dALK, Drosophila ALK | IL-3, interleukin-3 | CNS, central nervous system | JAK, Janus kinase | CML, chronic myeloid leukaemia | Jeb, jelly belly | IMT, inflammatory myofibroblastic tumour
Journal Article
Leukemia, ISSN 0887-6924, 12/2011, Volume 25, Issue 12, pp. 1882 - 1890
The anaplastic lymphoma kinase (ALK), tyrosine kinase oncogene is implicated in a wide variety of cancers... 
lymphomas | microRNA | VEGF | onco-ALK | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Humans | Gene Expression Regulation, Neoplastic | Neovascularization, Pathologic | MicroRNAs - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Case-Control Studies | Embryo, Mammalian - metabolism | Immunoenzyme Techniques | Hypoxia - metabolism | DNA Methylation | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Female | Real-Time Polymerase Chain Reaction | Lymphoma, Large-Cell, Anaplastic - metabolism | Fibroblasts - metabolism | Lymphoma, Large-Cell, Anaplastic - genetics | Enzyme-Linked Immunosorbent Assay | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Down-Regulation | RNA, Messenger - genetics | Cells, Cultured | Receptor Protein-Tyrosine Kinases - metabolism | Cell Adhesion | Blotting, Western | Blotting, Northern | Hypoxia - genetics | Animals | Receptor Protein-Tyrosine Kinases - genetics | Embryo, Mammalian - cytology | Hypoxia - pathology | Mice, Nude | Fibroblasts - cytology | Lymphoma, Large-Cell, Anaplastic - pathology | Mice | Mice, Inbred BALB C | MicroRNAs - genetics | Cell Movement | Physiological aspects | Lymphomas | Genetic aspects | Research | Neovascularization | Gene expression | Phosphotransferases | Carcinogenesis | Index Medicus | Life Sciences | Biochemistry, Molecular Biology
Journal Article
Journal Article
Cancer science, ISSN 1349-7006, 09/2019, Volume 110, Issue 10, pp. 3382 - 3390
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 08/2017, Volume 35, Issue 22, pp. 2490 - 2498
Journal Article